While l-DOPA–treated control mice rapidly developed dyskinesia, with a total dyskinetic event duration of 120 min, RGS4-lacking mice progressed to dyskinesia at slower rate, terminating the dyskinetic period faster, and with an attenuation of the AIMs peak (Fig. 5F). Here, RGS4 is linked to Dyskinesia.